Article
CVS Health's move to acquire Target's pharmacy business for $1.9 billion is a game changer in the pharmacy world.
CVS Health's move to acquire Target’s pharmacy business for $1.9 billion is a game changer in the pharmacy world.
The deal involves more than 1600 pharmacies and 80 clinics, which will continue to be located within Target stores but newly branded as CVS. However, sales from OTC drugs will still be controlled by Target.
This acquisition is expected to be a win-win for both retail giants, but that might not be the case for the pharmacy profession and the patients pharmacists serve.
There are a few outstanding questions:
After speaking with several of my colleagues, I am not the only one who feels this deal is a bad idea.
“The merge has taken another pharmacy choice away from patients. The monopoly they are slowly forming is dangerous to freedom of choice," independent community pharmacist John Paul Calvillo, PharmD, said. "...We are seeing the creation of a pharmacy monster that is changing the landscape of our profession.”
Clinical pharmacst Stephen Lozano, PharmD, BCACP, echoed those sentiments, stating, “It is a good business move for Target because it gets more people/traffic into their stores, but the CVS model is extremely capitalistic at the expense of patient care."
"...I feel it is a step back for the ultimate goal of community pharmacies, which is optimizing appropriate medication use, patient care, providing quality services and immunizations for the community, promoting public health, and advancing the practice of clinical community pharmacy," Dr. Lozano continued. "Target pharmacists will most likely start looking elsewhere, because Target was a platform that allowed individualized patient care. If they wanted to be pill pushers, they would have signed up for CVS or Walgreens to begin with.”
Trending tweets on the topic include:
Target expects the deal to close by the end of the year.